About AEI My AEI Support AEI Contact AEI
Home Events Books Short Publications Research Areas Scholars & Fellows


Search


FindAdvanced Search

Browse all short publications by:
- Date
- Subject
- Author
- Type
- Title

SHORT PUBLICATIONS
AEI Newsletter
AEI.org Exclusives
The American
Press Releases
Outlook Series
On the Issues
Papers and Studies
AEI Working Paper Series
Government Testimony
Speeches
Book Reviews
AEI Policy Series
The War on Terror

E-NEWSLETTERS
Enter e-mail:
 

Home >  Short Publications >  The Rush to Re-Regulate
The Rush to Re-Regulate
Print Mail
By Robert W. Hahn, Peter Passell
Posted: Wednesday, August 6, 2008
PAPERS AND STUDIES
AEI Center for Regulatory and Market Studies  (July 2008)
Publication Date: July 31, 2008

 
Senior Fellow
 Robert W. Hahn
 

Download file Click here to view the full text of this paper as an Adobe Acrobat PDF.

With Wall Street still reeling from the mortgage meltdown, the Federal Reserve now seemingly committed to rescuing big investment banks "too complex to fail," and the U.S. Treasury proposing a top-to-bottom reorganization of financial regulation, pieties about the virtues of unfettered markets now seem hollow. Tighter oversight of financial markets--reversing a trend that began in the 1970s with the end of fixed commissions on the U.S. stock exchanges--is thus almost certainly in the cards.

However, a little perspective is in order: re-regulation could have unintended consequences, bolstering the power of well-organized interest groups, reducing access to capital and undermining America's competitive position in the huge and growing global market for financial services. Hence the wisdom in pausing to remember both how easy it is to fall into bad regulation--and how hard it is to dig out. . . .

Download file Click here to view the full text of this paper as an Adobe Acrobat PDF.

Robert W. Hahn is a senior fellow at AEI and executive director of the AEI Reg-Markets Center. Peter Passell is a senior fellow at the Milken Institute.

Related Links
Related article on subprime loan regulation by Hahn
Related article on federal regulations by Hahn


Health Policy Outlook

In the latest Health Policy Outlook, John E. Calfee makes the case for substantial social gains from preserving several years of data exclusivity for firms innovating new biotech drugs.


Innovation and Technology Adoption in Health Care Markets
Innovation and Technology Adoption in Health Care Markets

Anupam B. Jena and Tomas J. Philipson argue that the use of cost-effectiveness analysis to curb health care spending may do more harm than good.